Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England

A global increase in the incidence of invasive group A Streptococcus (iGAS) infections was observed after lifting of COVID-19 related restrictions in 2022, and type M1UK dominated in many countries. After seasonal declines in iGAS incidence during the summer of 2023, simultaneous, rapid expansion o...

Full description

Saved in:
Bibliographic Details
Main Authors: Matthew A. Davies, Brechje de Gier, Rebecca L. Guy, Juliana Coelho, Alje P. van Dam, Robin van Houdt, Sébastien Matamoros, Marit van den Berg, Patrick E. Habermehl, Kartyk Moganeradj, Yan Ryan, Steve Platt, Henry Hearn, Eleanor Blakey, Darren Chooneea, Bart J.M. Vlaminckx, Theresa Lamagni, Nina M. van Sorge
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2025-02-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/31/2/24-0880_article
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850023498698719232
author Matthew A. Davies
Brechje de Gier
Rebecca L. Guy
Juliana Coelho
Alje P. van Dam
Robin van Houdt
Sébastien Matamoros
Marit van den Berg
Patrick E. Habermehl
Kartyk Moganeradj
Yan Ryan
Steve Platt
Henry Hearn
Eleanor Blakey
Darren Chooneea
Bart J.M. Vlaminckx
Theresa Lamagni
Nina M. van Sorge
author_facet Matthew A. Davies
Brechje de Gier
Rebecca L. Guy
Juliana Coelho
Alje P. van Dam
Robin van Houdt
Sébastien Matamoros
Marit van den Berg
Patrick E. Habermehl
Kartyk Moganeradj
Yan Ryan
Steve Platt
Henry Hearn
Eleanor Blakey
Darren Chooneea
Bart J.M. Vlaminckx
Theresa Lamagni
Nina M. van Sorge
author_sort Matthew A. Davies
collection DOAJ
description A global increase in the incidence of invasive group A Streptococcus (iGAS) infections was observed after lifting of COVID-19 related restrictions in 2022, and type M1UK dominated in many countries. After seasonal declines in iGAS incidence during the summer of 2023, simultaneous, rapid expansion of a previously rare emm type 3.93 was seen beginning in November, increasing to 20% of all cases in England and 60% of all cases in the Netherlands within 4 months. emm3.93 was associated with iGAS in children 6–17 years of age and with increased risk for pneumonia or pleural empyema and meningitis in both countries. No excess risk of death was identified for emm3.93 compared with other types. Genomic analysis of historic and contemporary emm3.93 isolates revealed the emergence of 3 new clades with a potentially advantageous genomic configuration. Our findings demonstrate the value of molecular surveillance, including long-read sequencing, in identifying clinical and public health threats.
format Article
id doaj-art-9d3fbcf2ec2b44beaab9f490070c1fab
institution DOAJ
issn 1080-6040
1080-6059
language English
publishDate 2025-02-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj-art-9d3fbcf2ec2b44beaab9f490070c1fab2025-08-20T03:01:22ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592025-02-0131222923610.3201/eid3102.240880Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and EnglandMatthew A. DaviesBrechje de GierRebecca L. GuyJuliana CoelhoAlje P. van DamRobin van HoudtSébastien MatamorosMarit van den BergPatrick E. HabermehlKartyk MoganeradjYan RyanSteve PlattHenry HearnEleanor BlakeyDarren ChooneeaBart J.M. VlaminckxTheresa LamagniNina M. van Sorge A global increase in the incidence of invasive group A Streptococcus (iGAS) infections was observed after lifting of COVID-19 related restrictions in 2022, and type M1UK dominated in many countries. After seasonal declines in iGAS incidence during the summer of 2023, simultaneous, rapid expansion of a previously rare emm type 3.93 was seen beginning in November, increasing to 20% of all cases in England and 60% of all cases in the Netherlands within 4 months. emm3.93 was associated with iGAS in children 6–17 years of age and with increased risk for pneumonia or pleural empyema and meningitis in both countries. No excess risk of death was identified for emm3.93 compared with other types. Genomic analysis of historic and contemporary emm3.93 isolates revealed the emergence of 3 new clades with a potentially advantageous genomic configuration. Our findings demonstrate the value of molecular surveillance, including long-read sequencing, in identifying clinical and public health threats. https://wwwnc.cdc.gov/eid/article/31/2/24-0880_articleStreptococcus pyogenesstreptococcipneumoniameningitis/encephalitisbacteriaepidemiology
spellingShingle Matthew A. Davies
Brechje de Gier
Rebecca L. Guy
Juliana Coelho
Alje P. van Dam
Robin van Houdt
Sébastien Matamoros
Marit van den Berg
Patrick E. Habermehl
Kartyk Moganeradj
Yan Ryan
Steve Platt
Henry Hearn
Eleanor Blakey
Darren Chooneea
Bart J.M. Vlaminckx
Theresa Lamagni
Nina M. van Sorge
Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
Emerging Infectious Diseases
Streptococcus pyogenes
streptococci
pneumonia
meningitis/encephalitis
bacteria
epidemiology
title Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
title_full Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
title_fullStr Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
title_full_unstemmed Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
title_short Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
title_sort streptococcus pyogenes emm type 3 93 emergence the netherlands and england
topic Streptococcus pyogenes
streptococci
pneumonia
meningitis/encephalitis
bacteria
epidemiology
url https://wwwnc.cdc.gov/eid/article/31/2/24-0880_article
work_keys_str_mv AT matthewadavies streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT brechjedegier streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT rebeccalguy streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT julianacoelho streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT aljepvandam streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT robinvanhoudt streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT sebastienmatamoros streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT maritvandenberg streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT patrickehabermehl streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT kartykmoganeradj streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT yanryan streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT steveplatt streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT henryhearn streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT eleanorblakey streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT darrenchooneea streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT bartjmvlaminckx streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT theresalamagni streptococcuspyogenesemmtype393emergencethenetherlandsandengland
AT ninamvansorge streptococcuspyogenesemmtype393emergencethenetherlandsandengland